AusBiotech Updates

Join the survey of Australian medical countermeasures

23 March 2017: The Australian life sciences industry is invited to assist in the 2017 National Capability Audit for the Medical Countermeasures (MCM) Initiative, to survey and understand Australias capability and capacity to support research and development for MCM p... | READ MORE

TGA seeks feedback on support needs for SMEs

21 March 2017: The TGA is investigating ways that it might provide support for small and medium enterprises (SMEs) in accessing regulatory guidance, and seeks feedback on the key themes that emerged in initial discussions with AusBiotech and industry. AusBiotech has... | READ MORE

Nine submissions done and two due by month end…

16 March 20017: Industry advocacy at AusBiotech is in top gear with nine submissions completed on behalf of members in the past 12 weeks and two due by the end of the month. AusBiotechs appearance today at the Senate Inquiry hearing into the Price regulation associa... | READ MORE

Senate inquiry to probe the complexity of prostheses pricing

14 March 2017: AusBiotech is set to give evidence at this weeks Senate Inquiry into the reform of prostheses pricing, which has proven to be a complex and confusing debate on how to best address the system of pricing products on the Prostheses List for implantable me... | READ MORE

Submission to Senate Inquiry seeks support for TGA Bill

9 March 2017: AusBiotech had made a submission to the Senate Inquiry on the Therapeutic Goods Amendment (2016 Measures No. 1) Bill 2016, urging that the Bill be supported to enable regulatory reform measures stemming from the review of Medicines and Medical Devices R... | READ MORE

Victoria launches new acceleration fund for medical research

7 March 2017: AusBiotech has welcomed the Victorian Medical Research Acceleration Fund, a new grant fund aiming to accelerate early-stage commercialisation of health and medical research and support its translation into health and economic outcomes. The competitive ... | READ MORE

Annual survey of biotech CEOs closing soon

2 March 2017: Industry CEOs are invited to contribute to AusBiotechs annual consultation on membership issues for biotechnology companies, which closes for 2017 on 17 March 2017. AusBiotech conducts the confidential CEO Biotechnology Industry Position Survey and sup... | READ MORE

Sinodinos announces intention for women's advisory roundtable

28 February 2017: The newly-appointed Minister for Industry, Innovation and Science, Senator Arthur Sinodinos, has announced an intention to establish a womens advisory to guide policy in the innovation sector. Addressing the Women in Venture Capital Forum last week... | READ MORE

Uncertainty on R and D Tax Incentive causing real harm

23 February 2017: Constant reviews and recent changes to the Research and Development (R&D) Tax Incentive are jeopardising Australian innovation and prompting Australian biotechnology firms to reconsider their R&D investment strategy, says the McKell Institute. ; ... | READ MORE

AusBiotech suggests FSANZ amend cost recovery plan

21 February 2017: AusBiotech has responded to Food Standards Australia New Zealand (FSANZ) call for comment on the draft Cost Recovery Implementation Statement (dCRIS), rejecting the proposed model to recover from industry direct and indirect costs of all FSANZ staff... | READ MORE

Previous page | Next page
Jump to page